Women receiving the HPV vaccine had a nearly 25% decrease in the proportion of cervical precancers due to HPV types 16 and 18, according to a recent CDC study presented at the 2018 Annual EIS Conference in Atlanta (abstract 4:10).
“The findings of this study further support the impact of the HPV vaccination program on cervical precancers in the U.S.,” said study author Nancy McCabe McClung, PhD, of the CDC’s National Center for Immunization and Respiratory